WestRiver led a $30m Series C funding round in Lumen Bioscience.

WestRiver, an investment firm, led a $30m Series C funding round in Lumen Bioscience, a clinical-stage biotechnology company, with participation from Gates Foundation, Matt Horner, Jim Kavanaugh, Adebayo Ogunlesi, Five Raynham, Jeff Raikes, David Siegel, Jerry Yang, and existing investors. “This milestone affirms the transformative power of spirulina-based GMP manufacturing. As our clinical programs continue to mature, we are thinking more and more about commercialization and distribution. The new investors joining us through WestRiver Group have built some of the world’s most impactful organizations in the past 40 years. We’re excited to be able to draw on their knowledge and expertise as we work to build Lumen into an enterprise with similar impact,” Brian Finrow, Lumen Bioscience CEO.